Approval · Notice of Compliance 1560 · 1999
PENTASA: Notice of Compliance 1560
Issued November 8, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1560
- Date
- November 8, 1999
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Change in product name
- Therapeutic class
- Lower gastrointestinal anti-inflammatory
Products in this notice
Medicinal ingredients
- MESALAZINE 1 G per 100ML
- MESALAZINE 2 G per 100ML
- MESALAZINE 4 G per 100ML
- MESALAZINE 1 G per SUP